Technical Analysis for GENE - Genetic Technologies Ltd

Grade Last Price % Change Price Change
grade F 0.83 5.06% 0.04
GENE closed up 5.06 percent on Thursday, January 17, 2019, on 72 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical GENE trend table...

Date Alert Name Type % Chg
Jan 17 Narrow Range Bar Range Contraction 0.00%
Jan 17 NR7 Range Contraction 0.00%
Jan 17 Wide Bands Range Expansion 0.00%
Jan 16 Wide Bands Range Expansion 5.06%
Jan 16 Overbought Stochastic Strength 5.06%
Jan 15 Wide Bands Range Expansion 5.06%
Jan 15 Overbought Stochastic Strength 5.06%
Jan 14 Weak + Overbought Other 0.00%
Jan 14 Wide Bands Range Expansion 0.00%
Jan 14 Overbought Stochastic Strength 0.00%

Older signals for GENE ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Genetic Technologies Limited provides genetic testing services. It offers a range of DNA based genetic tests for cancer predisposition, including breast cancer, ovarian cancer, bowel cancer, and uterine cancer; neurogenetic diagnostic assays; and gene testing for gene related disorders. The company also provides forensics tests, such as presumptive and confirmatory testing, individual DNA profiling, species identification, and animal forensic testing; paternity tests, which include antenatal, deceased estate, grandparent, immigration, legal paternity, non-legal paternity, sibling, twins, and Y-Chromosome DNA testing, as well as DNA profiling; and personal DNA testing comprising sports performance and ancestry gene testing. In addition, it offers animals' tests consisting of disease testing, breed identification, coat color, and forensic DNA testing, as well as DNA clinical services; and plant tests, including genomic and Xpress sequencing services. Further, the company is involved in the out-licensing of its intellectual property relating to non-coding DNA; and research and development activities in the areas of genetics and related fields. It operates in Australia, the United States, China, Canada, and Switzerland. The company was formerly known as Duketon Goldfields N.L. and changed it name to Genetic Technologies Limited in August 2000 as a result of the change in business from mining to biotechnology. Genetic Technologies Limited is headquartered in Fitzroy, Australia.
Is GENE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.05
52 Week Low 0.51
Average Volume 58,089
200-Day Moving Average 1.0966
50-Day Moving Average 0.9024
20-Day Moving Average 0.6788
10-Day Moving Average 0.7745
Average True Range 0.0693
ADX 26.21
+DI 23.9847
-DI 20.5731
Chandelier Exit (Long, 3 ATRs ) 0.6721
Chandelier Exit (Short, 3 ATRs ) 0.7179
Upper Bollinger Band 0.8961
Lower Bollinger Band 0.4615
Percent B (%b) 0.85
BandWidth 64.02475
MACD Line -0.0125
MACD Signal Line -0.0472
MACD Histogram 0.0347
Fundamentals Value
Market Cap 13.48 Million
Num Shares 16.2 Million
EPS -0.45
Price-to-Earnings (P/E) Ratio -1.84
Price-to-Sales 33.69
Price-to-Book 1.92
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.86
Resistance 3 (R3) 0.86 0.84 0.86
Resistance 2 (R2) 0.84 0.84 0.85 0.85
Resistance 1 (R1) 0.84 0.83 0.84 0.84 0.85
Pivot Point 0.82 0.82 0.83 0.83 0.82
Support 1 (S1) 0.82 0.82 0.82 0.82 0.81
Support 2 (S2) 0.80 0.81 0.81 0.81
Support 3 (S3) 0.80 0.80 0.81
Support 4 (S4) 0.80